State Street Corp Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

State Street Corp trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,110,382 shares of the company's stock after selling 103,803 shares during the quarter. State Street Corp owned about 4.90% of Henry Schein worth $445,447,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CWM LLC raised its position in shares of Henry Schein by 14.6% in the second quarter. CWM LLC now owns 6,672 shares of the company's stock valued at $428,000 after buying an additional 850 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Henry Schein by 64.4% during the 2nd quarter. SG Americas Securities LLC now owns 26,641 shares of the company's stock worth $1,708,000 after purchasing an additional 10,439 shares in the last quarter. Czech National Bank increased its position in shares of Henry Schein by 6.7% in the second quarter. Czech National Bank now owns 24,402 shares of the company's stock worth $1,564,000 after purchasing an additional 1,542 shares during the period. Sequoia Financial Advisors LLC raised its stake in Henry Schein by 3.2% in the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company's stock valued at $364,000 after purchasing an additional 176 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Henry Schein by 15.0% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 40,512 shares of the company's stock worth $2,597,000 after purchasing an additional 5,299 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Trading Down 0.3 %

Shares of NASDAQ:HSIC traded down $0.25 during trading on Tuesday, reaching $74.73. The stock had a trading volume of 1,183,942 shares, compared to its average volume of 1,399,355. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The firm's fifty day moving average is $71.83 and its 200 day moving average is $69.92. The stock has a market cap of $9.32 billion, a price-to-earnings ratio of 30.47, a P/E/G ratio of 2.09 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.32 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on HSIC shares. Barrington Research reissued an "outperform" rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective on the stock. Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $78.89.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.